|Bid||2.7400 x 1800|
|Ask||2.9900 x 800|
|Day's Range||2.7800 - 3.0000|
|52 Week Range||2.7600 - 6.5600|
|Beta (5Y Monthly)||1.08|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 23, 2022 - Mar 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.10|
Subscribe to Yahoo Finance Plus to view Fair Value for CBAYLearn more
Investment company LCM Capital Management Inc (Current Portfolio) buys Southern Co, Advanced Micro Devices Inc, Diageo PLC, Duke Energy Corp, Xcel Energy Inc, sells Tesla Inc, Biogen Inc, Yum China Holdings Inc, UiPath Inc, CymaBay Therapeutics Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, LCM Capital Management Inc.
Even if it's not a huge purchase, we think it was good to see that Dennis Kim, the Chief Medical Officer of CymaBay...
CymaBay Therapeutics Inc. (CBAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).